Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Levetiracetam (Keppra) to Improve Chronic Aphasia in Post-stroke Patients.

NCT00227461 is registered in ClinicalTrials.gov with Kessler Foundation as lead sponsor.

NCT NCT00227461
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00227461 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Levetiracetam (Keppra) to Improve Chronic Aphasia in Post-stroke Patients.
Lead sponsor
Kessler Foundation
Phase
Phase 1
Overall status
Unknown status
Start date
September 30, 2005
Completion date
December 31, 2021
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aphasia, stroke